The Question of Drug-Eluting Stent Safety: Then and Now

A well-publicized presentation at the 2006 meeting of the World Congress of Cardiology (WCC) raised questions about the safety of drug-eluting stents (DES), leading to a rapid change in clinical practices for patients undergoing percutaneous coronary interventions. Subsequent independent analyses, w...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2008-11, Vol.102 (9), p.12J-17J
Main Author: Spaulding, Christian, MD
Format: Article
Language:English
Subjects:
Angioplasty
Biological and medical sciences
Cardiology
Cardiology. Vascular system
Cardiovascular
Clinical medicine
Coronary Circulation
Coronary vessels
Drug therapy
Drug-Eluting Stents - adverse effects
Humans
Medical sciences
Stents
Studies
Transplants & implants
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A well-publicized presentation at the 2006 meeting of the World Congress of Cardiology (WCC) raised questions about the safety of drug-eluting stents (DES), leading to a rapid change in clinical practices for patients undergoing percutaneous coronary interventions. Subsequent independent analyses, which included patient-level data, found that DES, despite a small risk of very late stent thrombosis, are as safe as bare-metal stents and substantially reduce the risk of repeat revascularization. This article presents possible reasons for the differences between the conclusions of the 2006 WCC presentation and those of subsequent studies, and presents data that have emerged since the WCC 2006 meeting regarding the safety of DES.
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2008.09.004